|Year : 2017 | Volume
| Issue : 1 | Page : 109-111
Proteus syndrome with neurological manifestations: A rare presentation
Pallavi Sachdeva, Priyanka Minocha, Rohit Jain, Sadasivan Sitaraman, Manisha Goyal
Department of Pediatrics, Sawai Man Singh Medical College, Jaipur, Rajasthan, India
|Date of Web Publication||4-May-2017|
3327-A, Anand Nagar, Circular Road, Rewari - 123 401, Haryana
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Proteus syndrome (PS) is an extremely rare and complex disorder. Approximately 200 cases have been reported, and it seems to affect people of all ethnic and racial groups. PS is characterized by segmental overgrowth of multiple tissues and organs including vascular malformations, lipomatous overgrowth, hyperpigmentation, and various types of nevi. We hereby present a 7-year-old boy who presented with seizures and overgrowth of one-half of the body. Although classical physical features have been described, epilepsy and other neurological manifestations are rarely reported features of PS. Early detection of association of epilepsy and hemimegalencephaly with PS can prevent/minimize the neurological complications, disability, morbidity, and mortality.
Keywords: Epilepsy, hemimegalencephaly, overgrowth, Proteus syndrome
|How to cite this article:|
Sachdeva P, Minocha P, Jain R, Sitaraman S, Goyal M. Proteus syndrome with neurological manifestations: A rare presentation. J Pediatr Neurosci 2017;12:109-11
| Introduction|| |
Proteus syndrome (PS) (OMIM #176920) is a rare overgrowth syndrome characterized by segmental overgrowth of multiple tissues and organs including vascular malformations, lipomas, hyperpigmentation, and various types of nevi. Limb or digital overgrowth with partial gigantism is pathognomonic of PS. PS was originally described by Cohen and Hayden (1979) as a newly recognized disorder characterized by overgrowth of multiple tissues, connective tissue nevi, epidermal nevi, and hyperostoses. The disorder was designated PS by Wiedemann et al. in 1983. About 200 cases of PS have been reported in literature with the incidence of <1 in 1 million people worldwide.,, The exact cause, pathogenesis and embryologic origin of PS still remains a subject of discussion.,
| Case Report|| |
A 7 year old boy presented to us with complaints of seizures and overgrowth of the right half of the body. He was a third child born to the couple, out of nonconsanguineous marriage. Antenatal and perinatal period was uneventful. Parents noticed progressive overgrowth ofright foot from 3 to 4 months of age along with overgrowth of plantar surfaces. Few months later, overgrowth of the right half of face and gluteal region was also appreciated. The patient developed unprovoked seizures at 1½ month of age, initially left-sided hemiseizures, later on, became generalized and was started on antiepileptic drugs at the onset. Drug compliance was poor along with a history of recurrent seizures. Development milestones were appropriate for age.
On clinical examination, anthropometric measurements were within normal limits with normal intelligence. Examination of head and face revealed dolichocephaly, frontal bossing, hypertrophy of right half of face including cheek and tongue, hyperpigmented lesions over the right cheek, and right side of neck suggestive of nevus [Figure 1] and [Figure 2]. There was hypertrophy of right buttock and hyperpigmented lesions in right gluteal region. On examination of feet, there was macrodactyly of great, second, and third toe with splaying [Figure 3]a; and hypertrophy of plantar surfaces with increased rugosity [Figure 3]b.
|Figure 3: (a) Macrodactyly of both feet. (b) Increased plantar rugosities|
Click here to view
Investigations showed blood counts, renal and liver function tests within normal limits.
Magnetic resonance imaging brain showed right hemimegalencephaly with dysplasia with white matter abnormalities [Figure 4]a and [Figure 4]b. Electroencephalogram was abnormal showing generalized epileptiform discharges.
|Figure 4: (a and b) Magnetic resonance imaging brain: Megalencephaly right side|
Click here to view
| Discussion|| |
Our case was suspected to have PS based on characteristic facial features, skin abnormalities, dysmorphic growth, and overgrowth pattern.
PS can have varied manifestations. The characteristic features of PS include hemihypertrophy; generalized, unilateral, or localized disproportionate overgrowth of any tissue; distinctive facial features (macrocephaly, dolichocephaly, long face, downslanting palpebral fissures, and low nasal bridge); various capillary, venous and lymphatic malformations; and deep vein thrombosis.
Less common findings include CNS malformations such as hemimegalencephaly, cerebral arteriovenous malformations, abnormal gray-white matter differentiation, neuronal migration disorders, callosal dysgenesis, and hydrocephalus in brain radiology.,, Intellectual disability and seizures may be the presenting features in these individuals and such individuals may have associated distinct facial features. In our case, epilepsy and hemimegalencephaly were noted. The exact incidence of this association with PS is not exactly known as there are very few cases where this association has been reported.
The diagnosis of PS is primarily clinical based on the diagnosis criteria. Diagnosis can be confirmed by molecular genetic studies which includes exome sequencing for activating missense mutation in the AKT1 gene. As mutations occur during early development, the disorder is not inherited and does not run in families. Mutation in PTEN gene has also been reported in some case reports, but the association is not well established. In our case, genetic analysis was offered to the family but could not be performed as genetic testing is not currently available at our center and parents could not afford the investigation due to its high cost.
No specific treatment is available for PS. Management includes multidisciplinary treatment approach involving geneticist, neurologist, orthopedician, and dermatologist along with family support. The child was referred to orthopedic surgeon for the management of overgrown tissues. Antiepileptic drugs were revised, and family was counseled for drug compliance. The child is under regular follow-up for ensuring drug compliance and for monitoring of growth and secondary complications.
| Conclusion|| |
PS has various systemic abnormalities, a detailed and thorough clinical examination is essential in every child suspicious of PS.
In view of our case study, we value the importance of adopting multidisciplinary approach for early detection of functional disorders with special emphasis on neurological manifestations associated with this disorder and to minimize disabilities, reduce morbidity, and mortality associated with PS. We hope our case findings increase treating physician's/pediatrician's attention toward the possibility of diagnosing this association in PS patients.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ramasamy PP, Bharathi S, Eswaramoorthi B, Madhavan R, Maalik Babu AN. Proteus syndrome – Segmental overgrowth with multiple nevi. J Evol Med Dent Sci 2015;4:1388-93.
Biesecker LG, Happle R, Mulliken JB, Weksberg R, Graham JM Jr., Viljoen DL, et al
. Proteus syndrome: Diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet 1999;84:389-95.
Angurana SK, Angurana RS, Panigrahi I, Marwaha RK. Proteus syndrome: Clinical profile of six patients and review of literature. Indian J Hum Genet 2013;19:202-6.
] [Full text]
Sinha C, Gupta B, Kaur M, Kumar A, Dey CK. Proteus syndrome: A medical rarity. Saudi J Anaesth 2011;5:233-4.
] [Full text]
Dalal AB, Phadke SR, Pradhan M, Sharda S. Hemihyperplasia syndromes. Indian J Pediatr 2006;73:609-15.
Li Z, Shen J, Liang J. Thoracolumbar scoliosis in a patient with Proteus syndrome: A case report and literature review. Medicine (Baltimore) 2015;94:e360.
Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg E. The Proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr 1983;140:5-12.
Kaduthodil MJ, Prasad DS, Lowe AS, Punekar AS, Yeung S, Kay CL. Imaging manifestations in Proteus syndrome: An unusual multisystem developmental disorder. Br J Radiol 2014;85:e793-99.
Bastos H, da Silva PF, de Albuquerque MA, Mattos A, Riesgo RS, Ohlweiler L, et al
. Proteus syndrome associated with hemimegalencephaly and Ohtahara syndrome: Report of two cases. Seizure 2008;17:378-82.
Griffiths PD, Welch RJ, Gardner-Medwin D, Gholkar A, McAllister V. The radiological features of hemimegalencephaly including three cases associated with Proteus syndrome. Neuropediatrics 1994;25:140-4.
Cohen MM Jr. Proteus syndrome review: Molecular, clinical, and pathologic features. Clin Genet 2014;85:111-9.
Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, et al
. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011;365:611-9.
Barker K, Martinez A, Wang R, Bevan S, Murday V, Shipley J, et al
. PTEN mutations are uncommon in Proteus syndrome. J Med Genet 2001;38:480-1.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
|This article has been cited by|
||Proteus Syndrome, a rare case with an unusual presentation: Case report
| ||N. Amer, J. Al Helal, M. Al Hajji, A. Al Abduljabbar, M. Al Arfaj, H. Al Sadery, A. Awadallah |
| ||International Journal of Surgery Case Reports. 2020; 72: 339 |
|[Pubmed] | [DOI]|